Please assess the completion status of the following clinical trial:

Trial Title: Tofacitinib Ointment For Atopic Dermatitis (Atopic Eczema)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Have a clinical diagnosis of atopic dermatitis (also known as atopic eczema) for at least 6 months prior to Day 1 that has been clinically stable for at least 1 month prior to Day 1 and is confirmed to be atopic dermatitis according to the criteria of Hanifin and Rajka.~* Have a PGA score of 2 (mild) or 3 (moderate) at Day 1.~* Have atopic dermatitis on the head (including face, but excluding hair bearing scalp), neck, trunk (excluding groin and genitals), or limbs including palms and soles covering at least 2% of total body surface area (BSA) and up to and including 20% of total BSA at Day 1. At least 2% of the total BSA will need to be on the head (including face, but excluding hair bearing scalp), neck, trunk (excluding groin and genitals), or limbs (excluding palms and soles).~Exclusion Criteria:~* Evidence of certain skin conditions/infections at baseline~* Currently have atopic dermatitis on groin, genitals, palm or soles~* Have certain laboratory abnormalities at baseline~* Females who are pregnant, breastfeeding, or are of childbearing potential not using highly effective contraception

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Treatment group A (Type: EXPERIMENTAL): None
- Treatment B (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).